Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Research partner of the Dana-Farber Harvard Cancer Center; Level I trauma center verified by the American College of Surgeons [28] Part of the consortium of hospitals which operates Boston MedFlight [29] In 2003 the institution formed a partnership with the Boston Red Sox, becoming the official hospital of the team [30]
David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr. Livingston joined the Harvard faculty in 1973. [3]
In 1947, Sidney Farber founded the Dana-Farber Cancer Institute in Boston.The following year he launched the Jimmy Fund to raise money to support the hospital. [9] [10] The fund was named after a patient who was named "Jimmy" to protect his identity – his real name was Einar Gustafson and his identity was revealed in 1998.
Comprehensive cancer centers may apply for up to $1.5 million per year from the Department of Health and Human Services. [ 2 ] Clinical Cancer Centers generally conduct a combination of basic, population sciences, and clinical research, and are encouraged to stimulate collaborative research involving more than one field of study.
Broad Institute of MIT and Harvard, Cambridge, Massachusetts. The Eli and Edythe L. Broad Institute of MIT and Harvard (IPA: / b r oʊ d /, pronunciation respelling: BROHD), [1] often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States.
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Benjamin Levine Ebert, MD, PhD, is the president and CEO of Dana–Farber Cancer Institute, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and director of the Dana-Farber/Harvard Cancer Center. Ebert succeeded Laurie Glimcher as president and CEO in October 2024. [1]